American Oncology Stock Forecast - Period Momentum Indicator
| AONC Stock | 8.52 0.01 0.12% |
American Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast American Oncology stock prices and determine the direction of American Oncology Network's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of American Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
The current year's Fixed Asset Turnover is expected to grow to 21.23, whereas Inventory Turnover is forecasted to decline to 21.57. . The current year's Common Stock Shares Outstanding is expected to grow to about 21.3 M, whereas Net Income Applicable To Common Shares is forecasted to decline to about 2.1 M. | Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (0.11) | 0.01 |
| Check American Oncology Volatility | Backtest American Oncology | Information Ratio |
American Oncology Trading Date Momentum
| On October 20 2025 American Oncology Network was traded for 8.52 at the closing time. The top price for the day was 9.00 and the lowest listed price was 8.51 . There was no trading activity during the period 0.0. Lack of trading volume on October 20, 2025 did not affect price variability. The overall trading delta against the current closing price is 1.29% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare American Oncology to competition |
Other Forecasting Options for American Oncology
For every potential investor in American, whether a beginner or expert, American Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. American Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in American. Basic forecasting techniques help filter out the noise by identifying American Oncology's price trends.American Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with American Oncology stock to make a market-neutral strategy. Peer analysis of American Oncology could also be used in its relative valuation, which is a method of valuing American Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
American Oncology Network Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of American Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of American Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
American Oncology Market Strength Events
Market strength indicators help investors to evaluate how American Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading American Oncology shares will generate the highest return on investment. By undertsting and applying American Oncology stock market strength indicators, traders can identify American Oncology Network entry and exit signals to maximize returns.
American Oncology Risk Indicators
The analysis of American Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in American Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting american stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.03 | |||
| Standard Deviation | 6.56 | |||
| Variance | 43.01 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether American Oncology Network is a strong investment it is important to analyze American Oncology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact American Oncology's future performance. For an informed investment choice regarding American Stock, refer to the following important reports:Check out Historical Fundamental Analysis of American Oncology to cross-verify your projections. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of American Oncology. If investors know American will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about American Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.89) | Revenue Per Share | Quarterly Revenue Growth 0.514 | Return On Assets | Return On Equity |
The market value of American Oncology Network is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Oncology's value that differs from its market value or its book value, called intrinsic value, which is American Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because American Oncology's market value can be influenced by many factors that don't directly affect American Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between American Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if American Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, American Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.